Understanding the Pathophysiology and Pathogenesis of Bronchopulmonary Dysplasia

Berooster Gewdwe^*
*Correspondence: Berooster Gewdwe, Department of Clinical Medicine, Mercy University Hospital, T12 WE28 Cork, Ireland, Email:

Introduction

Bronchopulmonary Dysplasia (BPD) is a multifactorial chronic lung disease primarily affecting premature infants who require mechanical ventilation and oxygen therapy for respiratory support. Despite advances in neonatal care, BPD remains a significant complication associated with increased morbidity and mortality among preterm infants [1]. Bronchopulmonary dysplasia is a complex respiratory condition characterized by abnormal lung development and impaired gas exchange, primarily affecting premature infants. Despite advancements in neonatal intensive care, the incidence of BPD remains significant, particularly among extremely premature infants born before 28 weeks of gestation or those with very low birth weights. Understanding the pathophysiological mechanisms and underlying factors contributing to the development of BPD is crucial for improving preventative strategies and treatment approaches [2].

Description

The pathophysiology of BPD involves a cascade of events initiated by preterm birth, intrauterine insults and subsequent postnatal factors. Premature birth interrupts the normal lung development process, resulting in structural immaturity of the lungs, inadequate surfactant production and deficient alveolarization. The immature lung is particularly susceptible to injury from various insults, including mechanical ventilation, oxygen toxicity, inflammation and infection, which further exacerbate the lung injury and disrupt normal lung development. Alveolar simplification and dysmorphic development are hallmark features of BPD pathophysiology. Premature birth interrupts the physiological process of alveolarization, leading to decreased alveolar number and enlarged airspaces. This impairment in alveolar development compromises gas exchange and predisposes infants to chronic respiratory insufficiency [3].

Inflammatory processes play a central role in the pathogenesis of BPD. Premature infants are exposed to various inflammatory stimuli, including mechanical ventilation, infection and maternal chorioamnionitis. Inflammatory mediators, such as cytokines, chemokines and reactive oxygen species, contribute to lung injury, impaired alveolarization and fibrotic remodeling. Oxidative stress, resulting from an imbalance between reactive oxygen species and antioxidant defenses, further exacerbates lung injury and promotes inflammation-mediated damage [4]. Vascular abnormalities are another key component of BPD pathophysiology. Pulmonary hypertension and vascular remodeling contribute to pulmonary vascular resistance, impairing blood flow and exacerbating hypoxemia. Altered angiogenesis and dysregulated vascular growth factor signaling pathways play critical roles in the aberrant vascular development observed in BPD.

In addition to prenatal insults, various postnatal factors influence the development and severity of BPD. Mechanical ventilation strategies, oxygen supplementation, infections and nutritional deficiencies all contribute to lung injury and exacerbate the underlying pathophysiological processes. Strategies aimed at minimizing lung injury, optimizing respiratory support and promoting lung growth are essential for mitigating the risk of BPD in preterm infants [5].

Conclusion

Bronchopulmonary dysplasia remains a significant respiratory morbidity among premature infants, necessitating a comprehensive understanding of its pathophysiology and underlying mechanisms. The interplay between prenatal insults, postnatal factors, inflammation, oxidative stress and vascular remodeling contributes to the complex pathogenesis of BPD. Targeted interventions aimed at preventing lung injury, promoting alveolarization and minimizing inflammation is crucial for improving outcomes and reducing the burden of BPD in preterm infants. Continued research efforts are essential to unraveling the complexities of BPD pathophysiology and developing effective therapeutic strategies to mitigate its impact on neonatal health.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Bone, Roger C., Robert A. Balk, Frank B. Cerra and R. Phillip Dellinger, et al. "Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis."Chest101 (1992): 1644-1655.

   Google Scholar, Crossref, Indexed at

2. Finnerty, Celeste C., Nigel Tapiwa Mabvuure, Arham Ali and Rosemary A. Kozar, et al. "The surgically induced stress response."J Parenteral Enteral Nutr37 (2013): 21S-29S.

   Google Scholar, Crossref, Indexed at

3. Day, Colby L. and Rita M. Ryan. "Bronchopulmonary dysplasia: New becomes old again!."Pediatric Res81 (2017): 210-213.

   Google Scholar, Crossref, Indexed at

4. Mestan, Karen K. and Robin H. Steinhorn. "Fetal origins of neonatal lung disease: Understanding the pathogenesis of bronchopulmonary dysplasia."Ame J Physiol Lung Cell Mol Physiol301 (2011): L858-L859.

   Google Scholar, Crossref, Indexed at

5. Thekkeveedu, Renjithkumar Kalikkot, Milenka Cuevas Guaman and Binoy Shivanna. "Bronchopulmonary dysplasia: A review of pathogenesis and pathophysiology."Respiratory Med 132 (2017): 170-177.

   Google Scholar, Crossref, Indexed at